Sign in to view content

Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials

Caroline Baumal, MD, FASRS

Video
Published 2021

Related

Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2021
Episode 14: Plasma VEGF Levels After Anti-VEGF Injections (DRCR protocol T) with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
RO-104, a Novel Trispecific Antibody, Significantly Reduces Lesion Area and Vascular Leakage in a Laser-Induced Nonhuman Primate CNV Model
Harit K. Bhatt, MD, MBA, FASRS, FACS
Annual Meeting Talks
2025

Category: Diabetic Retinopathy

See more